Was just reading this in an article of news about Navartis that I saw on the Fox News Website & thought I would share it with y'all that might find it as interesting and I did:
Novartis was also confident about its oncology pipeline, which it expects to contribute more than $1 billion in sales by 2017, while it said recently launched Afinitor could have sales of $2 billion in advanced breast cancer by 2017. It is also hoping to convince doctors that they should switch patients onto Tasigna when one of its best-selling drugs Glivec loses patent exclusivity in 2015. Novartis plans to initiate further trials in 2013 to prove that patients with chronic myeloid leukemia who have taken Tasigna may be able to stop treatment once their cancer is under control. Read more: http://www.foxnews.com/health/2012/11/08/novartis-may-have-14-new-blockbuster-drugs-by-2017/#ixzz2BeeBS6GD Guess they need more money in their pockets as they certainly aren't making enough, huh? Suzieq -- [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/CMLHope
